• 9p21.3 Microdeletion involving <em>CDKN2A/2B</em> in a young patient with multiple primary cancers and review of the literature
• A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma
• A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
• A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma
• Anti-neuronal nuclear autoantibodies, types 1 and 2: their utility in the study of tumors of the nervous system
• Association of brain tumours with other neoplasms in families
• CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome
• Clinical and histopathologic features of paraneoplastic granuloma annulare in association with solid organ malignancies: A case-control study
• Cutaneous Melanoma and Glioblastoma Multiforme Association-Case Presentation and Literature Review
• Drug-induced hypersensitivity syndrome following temozolimide for glioblastoma multiforme and the role of desensitization therapy
• Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome
• Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria
• Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness
• Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome
• Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history
• Fast neutron beam radiotherapy at the University of Washington
• Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors
• Hereditary tumor syndromes and gliomas
• Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
• Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma
• Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome
• Malignant Peripheral Nerve Sheath Tumor in a Patient With BAP1 Tumor Predisposition Syndrome
• Multiple neurofibromas as the presenting feature of familial atypical multiple malignant melanoma (FAMMM) syndrome
• Newly Recognized Genetic Tumor Syndromes of the CNS in the 5th WHO Classification: Imaging Overview with Genetic Updates
• Nodular Melanoma in a 53-year-old Male with Glioblastoma Multiforme: A Rare Case Report
• Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas
• OMICS and biomarkers of glial tumors
• p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies
• Pineal region surgery. Experience in 22 patients
• Point mutation in p14^ARF -specific exon 1β of CDKN2A causing familial melanoma and astrocytoma
• Second malignant neoplasms following the treatment of brain tumors in children
• Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1
• Shoulder-hand syndrome in patients with intracranial neoplasms
• The genetics of hereditary melanoma and nevi. 1998 update
• Tolerance of normal human brain to boron neutron capture therapy